Search

Issue
Title
Authors
New aspects of the pathogenesis of psoriasis
Zhukov A.S., Patrushev A.V., Khairutdinov V.R., Samtsov A.V., Kryukov E.V.
Revisiting the question of psoriasis classification
Karamova A.E., Olisova O.Y., Bakulev A.L., Kokhan M.M., Khairutdinov V.R., Sokolovskiy E.V., Khobeych M.M.
The role of cells of the innate immune system in psoriasis
Sorokina E.V., Bisheva I.V.
Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts
Babkova M.I., Arshinsky M.I., Frolova Z.V., Chudina O.A., Mitrofanova J.S., Batalova S.K.
Resources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022
Kubanov A.A., Bogdanova E.V.
Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)
Kubanov A.A., Bogdanova E.V.
A prospective open-label study of the antifungal activity of external forms of activated zinc pyrithione in the treatment of Malassezia-associated skin diseases
Samtsov A.V., Patrushev A.V., Chepushtanova K.O., Bogdanova T.V., Alekssev A.Y., Bogomolova T.S., Vasilyeva N.V.
Anticytokine therapy with interleukin-17 in patients with moderate and severe psoriasis
Kovaleva J.S., Kazantsev I.V., Aibazova A.A., Ovchinnikova E.O., Garina A.A., Shabaldina A.P.
Langerhans cells and gamma delta Т-lymphocytes in the pathogenesis of psoriasis
Sorokina E.V., Kalinichenko E.O., Bisheva I.V., Stolpnikova V.N.
Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
Bogdanova E.V.
The peripheral blood regulatory T-cells analysis as a criterion for assessing the therapy efficacy and a prognostic marker for the duration of remission of psoriasis
Olisova O.Y., Gudova V.V.
Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial
Bakulev A.I., Samtsov A.V., Sokolovskiy E.V., Kokhan M.M., Khobeish M.M., Khairutdinov V.R., Karamova A.E., Olisova O.U., Ignatiev D.V., Nikiforova A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Influence of ABCB1 3435C>T polymorphism on methotrexate safety in patients with psoriasis
Kubanov A.A., Asoskova A.V., Zastrozhin M.S., Sozaeva Z.A., Sychev D.A.
Disorders of the skin microbiome in atopic dermatitis and psoriasis
Nikolaeva M.Y., Monakhov K.N., Sokolovskiy E.V.
Skin microbiota in patients with psoriasis vulgaris and pustular psoriasis
Bakhlykova E.A., Filimonkova N.N., Timokhina T.K., Kurlovich N.A.
Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice
Bakulev A.L., Pritulo O.A., Kuntsevich Z.S., Khotko A.A., Yunovidova A.A., Gorognichev P.V., Ziganshin O.R., Rudneva N.S., Bildyuk E.V., Repina T.V., Dudko V.Y., Maksimova M.D.
Epidemiology of psoriasis in the Russian Federation according to the patient registry
Kubanov A.A., Bogdanova E.V.
Search for predictors of psoriatic arthritis in patients with psoriasis
Artamonova O.G., Karamova A.E., Kubanov A.A., Verbenko D.A., Kozlova I.V.
Predictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)
Bogdanova E.V.
Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab
Bakulev A.L., Kruglova L.S.
Comprehensive assessment of the dynamics of angiogenesis in patients with psoriasis treated with methotrexate
Pritulo O.A., Petrov A.A.
Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade
Chikin V.V.
The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis
Bogdanova E.V.
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
Puig L., Bakulev A.L., Kokhan M.M., Samtsov A.V., Khairutdinov V.R., Morozova M.A., Zolkin N.A., Kuryshev I.V., Petrov A.N., Artemeva A.V., Zinkina-Orikhan A.V.
Assessment of CLA+T-cell subpopulations in the blood of patients with chronic dermatoses
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Soukharev A.V., Gumilevskaya O.P., Sukhina I.A.
The new external drug for the treatment of psoriasis based on inhibition of serine proteases
Zhukov A.S., Zharun E.R., Khairutdinov V.R., Samtsov A.V., Krasavin M.Y., Garabagiou A.V.
Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
Bakulev A.L.
Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Psoriasis incidence and prevalence in the Russian Federation
ZNAMENSKAYA L.F., MELEKHINA L.Y., BOGDANOVA Y.V., MINEYEVA A.A.
Precision therapy for psoriasis patients
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Psoriatic onychodystrophy: indices for assessing the severity of psoriatic onychodystrophy (part 2)
Platonova A.V., Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
The genetic factors in aetiology and pathogenesis of psoriasis
Kungurov N.V., Filimonkova N.N., Golubtsov V.I., Korkhmazova S.A.
Assessment of the clinical efficacy of the administration of Phosphogliv in complex treatment of psoriasis patients
Orlov Y.V., Konnov P.Y., Kotelnikova Y.V.
PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis
Kubanov A.A., Karamova A.E., Znamenskaya L.F., Chikin V.V., Kondrashova V.V.
Problems with differential diagnostics of seborrheic dermatitis and plaque psoriasis by the exampleof a particular case study
Samtsov A.V., SAMTSOV A.V.
Affected skin examination in psoriatic patients in the courseof Infliximab therapy (a morphologic analysis)
Katunina O.R., Znamenskaya L.F., Matushevskaya Y.I., Katunina O.R., Znamenskaya L.F., Matushevskaya Y.I.
Efficacy of repeated treatment courses of lactulose as a component of complex therapy in patients with psoriasis
Matusevich S.L., Medvedeva I.V.
Ademetionine in the cytostatic treatment of psoriasis
UGRYUMOVA Y.V.
External glucocorticosteroids: selection criteria in terms ofefficacy and safety
Belousova T.A., Goryachkina M.V., Belousova T.A., Goryachkina M.V.
Intestinal helminth and protozoan infections in patients withchronic dermatoses
Gerasimova N.A., Kokhan M.M., Belykh O.A., Keniksfest Y.V., Gerasimova N.A., Kokhan M.M., Belykh O.A., Keniksfest Y.V.
Role of CD11c-positive dendrite cells in the psoriasis pathogenesis
HAIRUTDINOV V.N.
Current topical therapy of psoriatic patients suffering from scalp lesions
FILIMONKOVA N.N., TOPYCHKANOVA Y.P.
Results of a study of genetic factors predisposing to the development of psoriasis among the population of the Russian Federation
MINEYEVA A.A., KOZHUSHNAYA O.S., ZNAMENSKAYA L.F., CHIKIN V.V., FRIGO N.V.
Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
Bakulev A.L., Samtsov A.V., Kubanov A.A., Khairutdinov V.R., Kokhan M.M., Artemyeva A.V., Derbin S.I., Chernyaeva E.V., Ivanov R.A.
Effectiveness of resuming ustekinumab therapy in psoriasis patients with metabolic disorders. Clinical experience
Rychkova I.V., Prytulo O.A.
THE ASSESSMENT OF THE INCIDENCE OF SKIN DISORDERS IN RUSSIAN FEDERATION IN 2003–2016
Kubanova A.A., Kubanov A.A., Melekhina L.E., Bogdanova E.V.
Analysis of methods common topical treatment of the generalized dermatoses in the delivery of the specialized health care in the profile "Dermatology"
Kokhan M.M., Samtsov A.V., Perlamutrov Y.N., Sokolovskiy E.V.
Using clobetasol propionate in the form of a shampoo for the treatment of patients suffering from psoriasis localized in the scalp area
Bakulev A.L., Kravchenya S.S., Igonina I.A., Utz S.R.
Dynamics of expression rates of growth factor proteins in psoriatic patients receiving a phototherapy
Chikin V.V., Zhilova M.B., Smolyannikova V.A., Nefedova M.A.
Particular features of lipid metabolism in psoriasis patients with concomitant metabolic syndrome
Pashinyan A.G., Dontsova Y.V.
Clinical evidence of therapy for genital psoriasis by biologic agents
Sokolovskiy E.V., Kokhan M.M.
Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19
Kubanov A.A., Bakulev A.L., Kokhan M.M., Olisova O.Y., Samtsov A.V., Sokolovskiy E.V., Khairutdinov V.R., Khobeish M.M.
Changes in the hormonal status of patients with focal psoriasis vulgaris
Vasil'ev A.G., Zaslavskiy D.V., Trashkov A.P., Kravtsova A.A., Kazikhanova S.R., Khayrutdinov V.R., Khvedelidze M.G., VASILIYEV A.G., ZASLAVSKY D.V., TRASHKOV A.P., KRAVTSOVA A.A., KAZIKHANOVA S.R., KHAIRUTDINOV V.R., KHVEDELIDZE M.G.
Proteome technologies in studying the pathogenesisof psoriasis
Znamenskaya L.F., Znamenskaya L.F.
Mechanism of the biological effect of the tumor necrosis factor-аlpha at psoriasis
ZNAMENSKAYA L.F., YEGOROVA Y.Y., ZITNER S.V.
Modern treatment methods for patients with psoriasis
Znamenskaya L.F., Yakovleva S.V., Volnukhin V.A., Pirogova E.V.
Studying of relationship of Histocompatibility antigens and N-acetylation phenotype in patients of Uzbek populations with psoriasis
IBRAGIMOV S.I., MANSUROVA G.T., MAMATKULOV U.A., MAKHSUDOV M.R.
Inhibitors of tumor necrosis factor-alpha for treatment ofpsoriatic patients
Znamenskaya L.F., Znamenskaya L.F.
TLR - possible molecular target for biologic psoriasis therapy
Katunina O.R., Rezaykina A.V.
Rational external therapy of scalp psoriasis
Perlamutrov Y.N., Olkhovskaya K.B.
Profiles of patients with psoriasis for appointment gene-engineering biological therapy — clinical justification
Zhukov A.S., Khotko A.A., Khairutdinov V.R., Samtsov A.V.
Influence of focal infection on the immune status of psoriasis patients
Patrushev A.V., Samtsov A.V., Nikitin V.Y., Sukharev A.V., Ivanov A.M., Gumilevskaya O.P., Sukhina I.A.
Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis
Samtsov A.V., Khairutdinov V.R., Bakulev A.L., Kubanov A.A., Karamova A.E., Artem’eva A.V., Korotaeva T.V.
Obesity related skin disorders
Gorlanov I.A., Zaslavskiy D.V., Leina L.M., Milyavskaya I.R.
A case of psoriasiform syphilid (from clinical practice)
Koshkin S.V., Chermnykh T.V., Kovrova O.S., Ryabov N.Y.
Endothelial dysfunction and its treatment in psoriasis patients
Shtoda Y.M., Slesarenko N.A., Bakulev A.L., Utz S.R., Platonova A.N.
Perspective trends of topical therapy of patients with psoriasis
Zhukov A.S., Khairutdinov V.R., Samtsov A.V.
Vulgar psoriasis and squamous cell carcinoma in a patient with discoid lupus erythematosus
Dubensky V.V., Nekrasova E.G., Alexandrova O.A., Muraveva E.S.
The role of T-regulatory cells in the pathogenesis of psoriasis
Khayrutdinov V.R., Mikhaylichenko A.F., Mukhina M.S., Samtsov A.V., Imyanitov E.N., Ivanov A.M., KHAIRUTDINOV V.R., MICHAILICHENCO A.F., MUKHINA M.A., SAMTSOV A.V., IMYANITOV E.N., IVANOV A.M.
A case study: combination of pemphigus foliaceus and psoriasis. Problems of diagnostics
NADGERIYEVA O.V., ZNAMENSKAYA L.F., AVDIYENKO I.N., KATUNINA O.R., MURUZOVA I.V.
Role of recognizing receptors in the initiation of immune inflammation in theskin of psoriasis patients
Katunina O.R., Rezaikina A.V., Kolykhalova O.I.
Clinical, molecular and genetic studies of efficacy and safety of using UV irradiation for psoriasis patients
Zhilova M.B., Kubanov A.A., Lesnaya I.N., Frigo N.V., Volkov I.A., Znamenskaya L.F., Volnukhin V.A.
Evaluation of clinical efficacy of treating patients sufferingfrom atopic dermatitis with drugs containing Aicida, anantiseptic stimulator of Dorogov
KLYuChAREVA S.V., PIRYaTINSKAYa V.A., KLYUCHAREVA S.V., PIRYATINSKAYA V.A.
A study of the efficacy of using the Kartalin ointment in a complex with exogenous melatonin for psoriasis
DMITRUK V.S., MARTYNOVA V.G., KAMYSHNIKOVA O.A., DMITRUK S.I.
Study of the genetic factors predisposing to the development of psoriasis
MINEEVA A.A., KOZHUSHNAYA O.S., VOLNUKHIN V.A., FRIGO N.V., ZNAMENSKAYA L.F., KUBANOV A.A., MELEKHINA L.E.
Experience of treatment of psoriatic patients with monochromic ultraviolet light from excimer lamps in a combination with external drugs
NEMCHANINOVA O.B.
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
Olisova O.Y., Svistunova D.A., Chernyavskaya L.M., Anpilogova E.M.
Features of treatment of patients with psoriasis with metabolic syndrome
Khairutdinov V.R., Samtsov A.V.
Signaling Рathway Blockers: Action Mechanism, Efficacy, Safety of Therapy for Patients with Psoriasis and Psoriatic Arthritis
Bakulev A.A.
Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients
Bakulev A.L.
The role of bacterial infection in the pathogenesis of psoriasis
Slesarenko N.A., Utz S.R.
Personalization of an anti-cytokine therapy of psoriatic patients
Kubanov A.A., Svishchenko S.I.
Features of the cytokine profile and the effectiveness of radical treatment of focal infection in patients with psoriasis
Patrushev A.V., Samtsov A.V., Soukharev A.V.
Immunohistochemical analysis of molecular cell structures of genetic and adaptive immunityin patients suffering from psoriasis in the course of biological therapy
Katunina O.R., KATUNINA O.R.
Evaluation of the efficacy of introduction of a new medical technology fortreatment of chronic dermatoses based on the application of activated zincpyrithione
Kubanov A.A., Petrovsky F.I.
Personalized approach to the selection of therapy for patients with psoriasisbased on the results of molecular and genetic tests
Znamenskaya L.F., Frigo N.V., Rotanov S.V., Volkov I.A., Volnukhin V.A., Zhilova M.B.
Assessment of the cytokine profile in psoriasis patients against the background of an immune-modulating therapy
OKHLOPKOV V.A., MEDVEDCHIKOV E.K., DOLGIKH T.I., PRAVDINA O.V., GORODILOV R.V., ZARAYEVA I.F.
Molecular Markers In Forecasting The Clinical Efficacy Of Infliximab In Psoriasis Patients
KUBANOVA A.A., LESNAYA I.N., FRIGO N.V., KAGANOVA N.L., ZNAMENSKAYA L.F., KUBANOV A.A.
Study of the genetic factors predisposing to the development of psoriasis
LVOV A.N., KATUNINA O.R., ZNAMENSKAYA L.F., MICHENKO A.V., EGOROVA Y.Y., INOYATOVA L.A., HAIRULLIN R.F., VOLKOV I.A.
Assessment of the efficacy of Betamethasone with Calcipotriol for isolated psoriatic nail affections based on optical coherent tomography
Neznakhina M.S., Petrova G.A., Garanina O.Y., Shlivko I.L.
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
Kubanov A.A., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Sokolovskiy E.V., Kokhan M.M., Artemyeva A.V., Chernyaeva E.V., Ivanov R.A.
Psoriasis: clinical and epidemiological features and therapy issues
Bakulev A.L., Fitileva T.V., Novodezerkina E.А., Gilloteau I., Tian Н., Howe T., Pietri G.
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
Namazova-Baranova L.S., Murashkin N.N., Ambarchyan E.T., Materikin A.I.
Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence
Bakulev A.L.
Evaluation of the efficacy and safety of combined treatment with methotrexate and a broadband medium-wave phototherapy for psoriasis patients
Grigoriyev D.V., Vladimirov V.V.
Epidemiology of psoriasis among the elderly population and volume of specialized medical care provided to patients with psoriasis in the Russian Federation in 2010–2019
Kubanov A.A., Bogdanova E.E.
The Actual Challenges of Biologics Treatment in Patients with Psoriasis
Bakulev A.L.
Markers of efficacy of Infliximab in psoriasis patients
Kubanova A.A., Znamenskaya L.F., Frigo N.V., Volkov I.A., Rotanov S.V., Rezaykina A.V., KUBANOVA A.A., ZNAMENSKAYA L.F., FRIGO N.V., VOLKOV I.A., ROTANOV S.V., REZAIKINA A.V.
Clobetasol propionate (Dermovate) gives new opportunities in the treatment ofdermatoses
Khlebnikova A.N.
Efficacy and safety of treatment of patients suffering from severe forms of psoriasis
BAKULEV A.L., KRAVCHENYA S.S., SLESARENKO N.A., SHABOGINA A.A.
1 - 100 of 159 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies